This process fosters a dynamic microenvironment marked by tissue repair and the presence of mediators such as IL-1, IL-10, and IL-7, which bolster the immune response and enhance therapeutic efficacy while mitigating tumor regrowth. This evidence concerns the gene IL1B and neoplasm.